Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation
Allergy, 2024
Zheng Y., Chen X., Wang Z., Cai S., Zheng M., Koh L., Common J., Man X.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Dermatological Diseases | Pathophysiology Patient Stratification | Serum |  Olink Target 96 |
Abstract
Palmoplantar pustulosis is a chronic, recurrent skin disorder characterized by sterile pustules and erythematous scaling on the palms and soles. In our study, dupilumab treatment showed efficacy and safety in PPP patients, potentially resulting from PPP patients’ serum Th2 signatures and the similarities between PPP and atopic dermatitis based on serum Olink proteomics.